Provided By PR Newswire
Last update: Mar 6, 2025
NEW YORK, March 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A/S (NYSE: NVO).
Shareholders who purchased shares of NVO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
Read more at prnewswire.com87.17
-0.87 (-0.99%)
Find more stocks in the Stock Screener
Uncover the potential of NOVO-NORDISK A/S-SPONS ADR, a growth stock reasonably priced. NYSE:NVO is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive valuation.